Side Table: The 340B Dilemma: Who Really Benefits?

Side Table: The 340B Dilemma: Who Really Benefits?

Author: The Doctor's Lounge November 4, 2025 Duration: 29:56

Send us a text

📌 Why Listen
Explore the complexities of the 340B program, its impact on healthcare systems, and the implications for both hospitals and independent clinicians. Understand the need for transparency and potential reforms to align the program with its original goals.


👥 Co-Hosts

  • Anthony DiGiorgio, DO, MHA – Neurosurgeon, UCSF; health policy researcher
  • Anish Koka, MD – Cardiologist, Philadelphia; healthcare policy commentator

📌 Episode Overview

In this episode, the hosts delve into the complexities of the 340B program, exploring its origins, current state, and the implications for hospitals and independent clinicians. They discuss how the program, initially intended to support hospitals serving low-income patients, has evolved into a significant revenue stream for large health systems, often at the expense of independent practices and without clear benefits to the intended beneficiaries. The conversation also touches on potential reforms and the need for greater transparency and accountability.


Episode Links
https://www.healthaffairs.org/content/forefront/340b-drug-pricing-program-capped-safety-net-grant

https://jamanetwork.com/journals/jama-health-forum/fullarticle/2821579


💬 Notable Quotes

  • "340B was created to help hospitals serving low-income patients."
  • "The program has expanded to include 60,000 sites."
  • "Hospitals can profit by reselling discounted drugs."
  • "Independent clinicians face competitive disadvantages."
  • "340B funds are not always used for patient care."

📚 What You’ll Learn

  • The origins and current state of the 340B program.
  • How hospitals leverage the program for revenue.
  • The competitive disadvantages faced by independent clinicians.
  • The lack of transparency in fund usage.
  • Potential reforms to align the program with its original goals.

⏱ The Episode (Timestamps)

  • 00:00:00 Introduction to 340B
  • 00:03:00 The MRI Discussion
  • 00:09:00 340B Program Origins
  • 00:18:00 Current State of 340B
  • 00:27:00 Implications for Clinicians
  • 00:36:00 Calls for Reform


🔗 Connect with the Hosts:

• Dutch Rojas on X

• Dr. Anthony DiGiorgio on X

• Dr. Anish Koka on X

• Dr. Dan Choi on X

Dr. Sanat Dixit on X


In The Doctor's Lounge, the white coat comes off for a conversation that moves freely from the exam room to the boardroom. This isn't a lecture hall; it's the back table where practicing physicians gather to unpack the complex systems that define modern medicine. Hosted by Dutch Rojas and Anthony DiGiorgio, DO, with regular voices like Anish Koka, MD, Dan Choi, MD, and Sanat Dixit, MD, the discussions are built on frontline experience. You'll hear unfiltered perspectives on the policy debates that shape care, the realities of navigating business and entrepreneurship within a medical practice, and the constant push for meaningful reform. The dialogue is grounded in a shared commitment to physician autonomy and, ultimately, better patient outcomes. Each episode in this podcast connects the dots between clinical fitness and the health of the medical profession itself, offering a rare look at the challenges and opportunities that exist where patient care meets the mechanics of the healthcare industry. It's a space for the nuanced, often contentious, and always real conversations happening behind the scenes.
Author: Language: English Episodes: 61

The Doctor's Lounge
Podcast Episodes
The ER Doc Who Quit the System  - and Built His Own [not-audio_url] [/not-audio_url]

Duration: 1:02:16
Episode SummaryDr. Noah Kaufman - board-certified emergency physician with 20 years in the ER, seven seasons on American Ninja Warrior, and a new direct acute care practice in Denver - joins Drs. Koka and DiGiorgio to ta…
The FDA, Unicure, and the Limits of Accelerated Approval [not-audio_url] [/not-audio_url]

Duration: 53:09
Episode SummaryAnish sits down with Adu, a med student and biotech investor, to work through the FDA's contested handling of Unicure's AMT-130 — a gene therapy for Huntington's disease delivered via stereotactic brain in…
Free Markets, Private Equity, and the Moral Case for Medicine [not-audio_url] [/not-audio_url]

Duration: 1:26:47
Episode SummaryJared Rhoads, founder of the Center for Modern Health and senior lecturer in health policy at the Dartmouth Institute, joins Drs. Koka and DiGiorgio for a wide-ranging conversation on the philosophical fou…
From Babylon to Baylor: How Insurance Went Off the Rails [not-audio_url] [/not-audio_url]

Duration: 34:01
Anish and Dr. DiGiorgio trace the history of insurance from ancient Babylonian bottomery contracts through Egyptian workers' guilds, Greek risk-pooling societies, Lloyd's of London, and the birth of actuarial science — t…